Out-of-pocket health care expenditures among older Americans with dementia

Alzheimer Disease and Associated Disorders

Volumn 18, Issue 2, 2004, Pages 90-98

  Langa, Kenneth M ^a,b,c,d,e   Larson, Eric B ^g   Wallace, Robert B ^h   Fendrick, A Mark ^a,f   Foster, Norman L ^a   Kabeto, Mohammed U ^a,d,e   Weir, David R ^c   Willis, Robert J ^c   Herzog, A Regula ^c  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

^d UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^e SGIM Collab Ctr for Res and Educ   (United States)

^f UNIVERSITY OF MICHIGAN SCHOOL OF PUBLIC HEALTH   (United States)

^g Grp Hlth Coop Ctr Hlth Studs   (United States)

^h UNIVERSITY OF IOWA   (United States)

Author keywords

Dementia; Elderly; Health care expenditures; Medicaid; Medicare

Indexed keywords

NOOTROPIC AGENT;

AGED; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; FAMILY; FEMALE; FINANCIAL MANAGEMENT; GERIATRIC CARE; HEALTH CARE COST; HEALTH SURVEY; HOSPITALIZATION; HUMAN; INTERVIEW; LONG TERM CARE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICAL CARE; MEDICARE; NURSING HOME; PRESCRIPTION; PRIORITY JOURNAL; SELF REPORT; TELEPHONE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; COSTS AND COST ANALYSIS; DATA INTERPRETATION, STATISTICAL; FEMALE; FINANCING, PERSONAL; HEALTH CARE COSTS; HEALTH EXPENDITURES; HEALTH SURVEYS; HUMANS; INSURANCE COVERAGE; LONGITUDINAL STUDIES; MALE;

EID: 2942593701     PISSN: 08930341     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.wad.0000126620.73791.3e     Document Type: Article

References (45)

1. Gross D, Brangan N. Out-of-Pocket Spending on Health Care by Medicare Beneficiaries Age 65 and Older: 1999 Projections (Issue Brief). Public Policy Inst (Am Assoc Retired Pers), 1999:1-14.
2. Crystal S, Johnson R, Harman J, et al. Out-of-pocket health care costs among older Americans. J Gerontol B Soc Sci. 2000;55(suppl):51-62.
3. Hwang W, Weller W, Ireys H, et al. Out-of-pocket medical spending for care of chronic conditions. Health Aff. 2001;20:267-278.
4. Soumerai S, Ross-Degnan D. Inadequate prescription-drug coverage for Medicare enrollees: a call to action. N Engl J Med. 1999;340:722-728.
5. Cassel CK, Besdine RW, Siegel LC. Restructuring Medicare for the next century: what will beneficiaries really need? Health Aff. 1999;18:118-131.
6. Altman BM, Cooper PF, Cunningham PJ. The case of disability in the family: impact on health care utilization and expenditures for nondisabled members. Milbank Q. 1999;77:39-75.
7. Fendrick AM, Smith D, Chernew M, et al. A benefit-based copay for prescription drugs: patient contribution based on total benefits, not drug acquisition cost. Am J Manag Care. 2001;7:861-867.
8. Steinman M, Sands L, Covinsky K. Self-restriction of medications due to cost in seniors without prescription coverage. J Gen Intern Med. 2001;16:793-799.
9. Federman AD, Adams AS, Ross-Degnan D, et al. Supplemental insurance and use of effective cardiovascular drugs among elderly medicare beneficiaries with coronary heart disease. JAMA. 2001;286:1732-1739.
10. Gross D, Alecxih L, Gibson M, et al. Out-of-pocket health spending by poor and near-poor elderly Medicare beneficiaries. Health Serv Res. 1999;34:241-254.
11. Hoffman C, Rice D, Sung H. Persons with chronic conditions: their prevalence and costs, JAMA. 1996;276:1473-1479.
12. Brookmeyer R, Gray S, Kawas C. Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset. Am J Public Health. 1998;88:1337-1342.
13. U.S. General Accounting Office. Alzheimer's Disease: Estimates of Prevalence in the United States. Washington, DC: U.S. General Accounting Office, 1998.
14. Knickman J, Snell E. The 2030 problem: caring for aging baby boomers. Health Serv Res. 2002;37:849-884.
15. Brummel-Smith K, Weiner M, Powe N, et al. Alzheimer's disease under managed care: implications from Medicare utilization and expenditure patterns. J Am Geriatr Soc. 1998;46:762-771.
16. Gutterman E, Markowitz A, Lewis B, et al. Cost of Alzheimer's disease and related dementia in managed-Medicare. J Am Geriatr Soc. 1999;47:1065-1073.
17. Taylor D, Sloan F. How much do persons with Alzheimer's disease cost Medicare? J Am Geriatr Soc. 2000;48:639-646.
18. Hill J, Futterman R, Duttagupta S, et al. Alzheimer's disease and related dementias increase costs of comorbidities in managed Medicare. Neurology. 2002;58:62-70.
19. McCormick W, Hardy J, Kukull W, et al. Healthcare utilization and costs in managed care patients with Alzheimer's disease during the last few years of life. JAm Geriatr Soc. 2001;49:1156-1160.
20. Walsh EG, Wu B, Mitchell JB, et al. Cognitive function and acute care utilization. J Gerontol B Psychol Sci Soc Sci. 2003;58(suppl):38-49.
21. Newcomer R, Clay T, Luxenberg J, et al. Misclassification and selection bias when identifying Alzheimer's disease solely from Medicare claims records. JAm Geriatr Soc. 1999;47:215-221.
22. Welch GH, Walsh J, Larson EB. The cost of institutional care in Alzheimer's disease: nursing home and hospital use in a prospective cohort. J Am Geriatr Soc. 1992;40:221-224.
23. Brodaty H, McGilchrist C, Harris L, et al. Time until institutionalization and death in patients with dementia. Arch Neurol. 1993;50:643-650.
24. Smith GE, O'Brien PC, Ivnik RJ, et al. Prospective analysis of risk factors for nursing home placement of dementia patients. Neurology. 2001;57:1467-1473.
25. Yaffe K, Fox P, Newcomer R, et al. Patient and caregiver characteristics and nursing home placement in patients with dementia. JAMA. 2002;287:2090.
26. Kemper P. The use of formal and informal home care by the disabled elderly. Health Serv Res. 1992;27:421-451.
27. Langa K, Chernew M, Kabeto M, et al. The explosion in paid home health care in the 1990's: who received the additional services? Med Care. 2001;39:147-157.
28. Soldo BJ, Hurd MD, Rodgers WL, et al. Asset and health dynamics among the oldest old: an overview of the AHEAD Study. J Gerontol B Psychol Sci Soc Sci. 1997;52:1-20.
29. Heeringa S, Hill D, Howell D. Unfolding Brackets for Reducing Item Nonresponse in Economic Surveys. Ann Arbor, MI: Health and Retirement Study Working Paper Series, 1995.
30. Cao H. Impute: a SAS application system for missing value imputations [Web Page]. July 2001. Available at: http://www.umich.edu/~hrswww/docs/userg/dr-007.pdf. Accessed June 27, 2003.
31. Folstein MF, Folstein SE, McHugh PR. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975;12:189-198.
32. Brandt J, Spencer M, Folstein M. The telephone interview for cognitive status. Neuropsychiatry Neuropsychol Behav Neurol. 1988;1:111-117.
33. Welsh K, Breitner J, Magruder-Habib K. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993;6:103-110.
34. Plassman BL, Newman T, Welsh K, et al. Properties of the telephone interview for cognitive status: application in epidemiological and longitudinal studies. Neuropsychiatry Neuropsychol Behav Neurol. 1994;7:235-241.
35. Herzog A, Wallace R. Measures of cognitive functioning in the AHEAD Study. J GerontolB Psychol Sci Soc Sci. 1997;52:37-48.
36. Langa K, Chemew M, Kabeto MU, et al. National estimates of the quantity and cost of informal caregiving for the elderly with dementia. J Gen Intern Med. 2001;16:770-778.
37. Banaszak-Holl J, Fendrick AM, Foster N, et al. Predicting nursing home admission: estimates from a 7-year follow-up of a nationally representative sample of older Americans. Alzheimer Dis Assoc Disord. 2004;18.
38. Duan N, Manning WG, Morris CN, et al. A comparison of alternative models for the demand for medical care. J Business Econ Stat. 1983;1:115-126.
39. Manning WG. The logged dependent variable, heteroscedasticity, and the retransformation problem. JHealth Econ. 1998;17:283-295.
40. Eppig F, Chulis G. Matching MCBS (Medicare Current Beneficiary Survey) and Medicare data: the best of both worlds. Health Care Financ Rev. 1997;18:211-229.
41. Lubitz J, Riley G. Trends in Medicare payments in the last year of life. N Engl J Med. 1993;328:1092-1096.
42. Thomas C, Ritter G, Wallack S. Growth in prescription drug spending among insured elders. Health Aff. 2001;20:265-277.
43. Trinh N, Hoblyn J, Mohanty S, et al. Efficacy of cholinesterase inhibitors in the treatment of neuropsychiatric symptoms and functional impairment in Alzheimer disease: a meta analysis. JAMA. 2003;289:210-216.
44. Knopman D, Schneider L, Davis K, et al. Long-term tacrine (Cognex) treatment: effects on nursing home placement and mortality. Tacrine Study Group. Neurology. 1996;47:166-177.
45. Bishop C. Where are the missing elders? The decline in nursing home use, 1985 and 1995. Health Aff. 1999;18:146-155.